SeptRx

SeptRx

United states-based medical device company developing minimally invasive treatments for structural heart defects.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD17—25m (Dealroom.co estimates Jun 2011.)
Fremont California (HQ)
  • Edit
DateInvestorsAmountRound

$2.7m

Series A
Total FundingAUD4.2m

Recent News about SeptRx

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.